Anna Ferrari

14PUBLICATIONS

47CO-AUTHORS

Haematological tumoursMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersImmunogenetics (incl. genetic immunology)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (14)

Sort by Publication Date:

|Jun 24, 2026

Retraction Note: MEK1/2 regulate normal BCR and ABL1 tumor-suppressor functions to dictate ATO response in TKI-resistant Ph+ leukemia.

|Sep 27, 2025

Unveiling Cryptic BCR-ABL1 Rearrangements: Diagnostic Challenges and Clinical Impact in Myeloid Malignancies.

Anna Ferrari, Chiara Salvesi, Eugenio Fonzi

|Nov 26, 2024

Exploring the role of PARP1 inhibition in enhancing antibody-drug conjugate therapy for acute leukemias: insights from DNA damage response pathway interactions.

Andrea Ghelli Luserna di Rorà, Mouna Jandoubi, Antonella Padella

|Jan 11, 2024

ETV6::ABL1-Positive Myeloid Neoplasm: A Case of a Durable Response to Imatinib Mesylate without Additional or Previous Treatment.

Maria Teresa Bochicchio, Giovanni Marconi, Carmen Baldazzi

|Jun 29, 2023

MEK1/2 regulate normal BCR and ABL1 tumor-suppressor functions to dictate ATO response in TKI-resistant Ph+ leukemia.

Laura Mazzera, Manuela Abeltino, Guerino Lombardi

|Apr 28, 2023

Detection of a Novel MSI2-C17orf64 Transcript in a Patient with Aggressive Adenocarcinoma of the Gastroesophageal Junction: A Case Report.

Anna Ferrari, Roberto Fiocca, Elena Bonora

Pageof 3

Frequent Collaborators

Michela Rondoni

Eugenio Fonzi

Giorgia Simonetti

Antonella Padella

Giovanni Marconi

Alberto Bongiovanni

Ilaria Iacobucci

Toni Ibrahim

Claudia Cocchi

Alessandro De Vita

Frequent Collaborators

Michela Rondoni

Eugenio Fonzi

Giorgia Simonetti

Antonella Padella